Moneycontrol PRO
HomeNewsBusinessCompaniesFive things you need to pay attention to while choosing a Covid-19 vaccine

Five things you need to pay attention to while choosing a Covid-19 vaccine

Companies across the globe are in a race to develop vaccines, and some, such as the Pfizer and Moderna vaccines, may be rolled out soon if regulators give them the go-ahead. But from having nothing to being asked to choose from multiple options will prove a challenge for many. Consumers will have to weigh many pros and cons, including price and potential adverse effects. We give you the lowdown on what to look at while choosing a vaccine

December 09, 2020 / 20:56 IST
 With several Covid-19 vaccines expected to be ready for release soon, there is confusion among consumers over which vaccine is best for them. To be sure not everybody will get to choose their vaccine in the initial months when the government rolls out the vaccination drive. But once more vaccines are approved and available, there will be a choice, at least in the private market. That also leads to a dilemma on which vaccine to pick from those that will be available.
Here are the key points that you need to focus on in choosing a vaccine:
Vaccine maker's reputation
Experts say the track record or reputation of the vaccine maker matters a lot.
“The first thing to look at is, who developed this vaccine, and what has been their history and track record in producing safe vaccines,” says Davinder Gill, entrepreneur, and former CEO of Hilleman Laboratories, which develops novel vaccines.
Gill says a good track record will give him confidence that the vaccine has been properly tested in terms of safety and efficacy, as a lot rides on the reputation of the vaccine maker.
Manufacturing track record 
Experts also say that the manufacturing track record of the vaccine maker is equally important. Vaccine manufacturing is a complex operation. Any deviation in current good manufacturing practices may lead to cross-contamination and a substandard product that may not have the intended benefit but instead cause harm to consumers.
“If a manufacturer takes shortcuts to produce something quickly and sell it cheaply, it can create problems like side-effects and other issues,” Gill says. He adds that people should pay attention to red flags raised by regulators such as the DCGI and USFDA, as well as by the WHO.
Reactogenicity
Reactogenicity refers to reactions that occur soon after vaccination. These may include local reactions such as pain, swelling, or redness where the shot was given. These are quite common. The other reactions are fever, fatigue, tiredness, headache and joint aches, which begin within 24 hours and last for up to two days. The reactogenicity can make the person who is vaccinated stay at home and not go to work for a day or two. So, one needs to check with a doctor on the reactogenicity of the vaccine. Ideally a vaccine that has low reactogenicity is preferable.
Affordability
Affordability will play a role in the vaccines people choose. Each Covid vaccine will be priced at different points based on the brand, novelty of the platform, cold chain requirements and other factors. It is up to the consumer to choose a vaccine that is light on his or her pocket. But a safe vaccine that offers assured protection against Covid-19 is a good investment, even if it is not easy on the pocket.
Convenience
This could be another major factor that will sway people in choosing a vaccine. For instance, a single-dose vaccine is much more convenient than a two-dose vaccine. A vaccine that can be inhaled is also more convenient, especially for children and older people. But these vaccines will take more time to hit the market.
Viswanath Pilla
Viswanath Pilla is a business journalist with 14 years of reporting experience. Based in Mumbai, Pilla covers pharma, healthcare and infrastructure sectors for Moneycontrol.
first published: Dec 9, 2020 05:35 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347